Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena - Fierce Biotech
Eli Lilly has become the latest Big Pharma to buy itself a corner of the in vivo CAR-T space via the
Search Group
Share To
Comments
About Screade
Screade® Inc. version c2ebf08, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments